The great BIO world meet, held in Boston this year, will once again be a showcase for booming French biotechnology which is asserting its position within the group of front runners driving the sector.  From June 18th to June 21th, there will be 90 companies, most of which belong to a competitiveness cluster, present in the French pavilion run by UBIFRANCE. Founded in 2005, competitiveness clusters assemble the foremost private or public players in their respective sectors, thus facilitating partnerships between the world of business and the world of research aiming at a common strategy in developing high potential technology.The seven clusters attending BIO 2012 are involved in specific avenues and have established numerous links with foreign clusters. France has set innovation at the heart of its economic and industrial policy. Competitiveness clusters provide efficient coordination of R&D and technology transfer by gathering in one place the players in the worlds of research, business and education. The idea is to make use of the synergies thus created and of collaborative, innovative projects to help the companies gain a favourable position on the world market. French biotech companies: businesses, research laboratories, clusters and public agencies will be attending BIO 2012 in Boston. They are the key players in those changes. Their dynamic approach is worth your interest. All of the issues will be addressed: infectious diseases immunology, genetics, inflammatory diseases, metabolic diseases,nutrition/health, orphan diseases, cancer, CNS, etc. More information on our website . Follow us on Twitter or Facebook , and join our French / North American Biotech Business Group on LinkedIn.  

  Watch the following video and listen to Philippe Neuville, PhD, Chief Executive Director at Domain Therapeutics, who attended the previous French Biotech Tour.      

  All the French participants are now registered for the new French Biotech Tour! Join us at the Courtyard Downtown Philadelphia Hotel and meet with the 15 French Companies and Bioclusters.   Be there on Thursday, May 24th to meet with -           Affilogic (developing custom proprietary affinity proteins), -           Alsace Biovalley   (French BioCluster), -          AltraBio (providing integrative analysis of life science data), -          Atlanpole Biotherapies   (French BioCluster), -          Biofilm Control (Alerting, diagnostics and theranostics tests), -          Bionext (Tissue and Genome-based Drug and Interactome Designer), -          BioSIMS Technologies (providing next generation protein microarray services and technologies), -          Erytech Pharma (developing medicinal products for oncology based on the use of human red blood cell), -          Firalis SAS (providing integrative biomarker solutions to support drug development), -          Institut de Recherche Pierre Fabre (Discovery, research and development activities of anticancer compound for Pierre Fabre Pharmaceutical company), -           LyonBioPole (French BioCluster), -          Medicen Paris Region (French BioCluster), -          NETRIS Pharma (developing drug candidates for personalized medicine in oncology), -            Quinten ( First choice partner for biomarker discovery & validation), -          The CoSMo Company (Next generation multiscale and trans-scale modeling and simulation). You can get more information about our attendees and request meetings with them on http://frenchbiotechtour.ubifrance-events.com   Two moderators from the Johns Hopkins Technology Transfer   and UPStart at the University of Pennsylvania   will also be at the event!   Several US-based companies have already decided to participate! Who is next ?     Follow us on Twitter   and Facebook , and join our French Biotech Tour Group   on LinkedIn  

<p>The French Biotechnology Clusters and UBIFRANCE are pleased to announce the 6th edition of &ldquo;THE FRENCH BIOTECH TOUR&rdquo;. This new edition will explore the theme of BIOMARKERS AND PERSONALIZED MEDICINE.&nbsp;&nbsp; <br /> This new edition will be held in Philadelphia, on May, 24th 2012 from 9am to 6pm.</p>  <p> What is the French Biotech Tour ?<br /> It is a unique one-day partnering event, opened to pharmaceutical and biotechnology companies, research and academic institutions.<br /> It consists of: <br /> -&nbsp;Presentations from industry experts (French and American)<br /> -&nbsp;One on one business meetings with potential partners and collaborators<br /> -&nbsp;Networking opportunities</p> <p>The objective of this event is to provide US and French biotech and pharma companies, working in Biomarkers and Personalized Medicine, with the opportunity to explore transatlantic partnerships (licensing, R&amp;D collaborations, etc.).</p>  <p>For further information on the FRENCH BIOTECH TOUR, please visit our website , follow us on twitter or join our French / North American Healthcare Business Group on LinkedIn.</p>

The first edition of the French Sourcing Pharma Tour / BioNJ Partnering will take place on the prestigious campus of Princeton from May 9 th to May 11 th . With an emphasis on partnering sessions and company presentation opportunities, this event will attract senior life science executives from global biotech and pharmaceutical companies, the funding community and entrepreneurs from throughout the Eastern United States, Europe, Asia and beyond. New Jersey is a very attractive region with a high concentration of famous companies as Abbott, J & J, Pfizer, Merck, BMS, GSK, AstraZeneca, Sanofi , Amgen, Novartis, Roche, Biogen... Thanks to this attractiveness, more than 200 American entities from various areas are expected:  innovatives biotechnologies,  processes applied to drugs and biologics,  equipment and laboratory instruments, shaping and drug packaging, C MO (production, logistics), and  CRO (preclinical studies, clinical trials, data mining ...). As a reminder, France is, according the IMS Health (world’s leading research and consulting for the drug industry), the biggest European market with Germany in terms of value and production. 250 companies are specialized in biotechnology, and for the period of 2010 to 2015, the French biotechnology market is forecast to increase of 32% to a value of $6.2 billion. To sustain and develop more and more its innovation power, French companies has to find and invest in the right partners. Participate to the French Sourcing Pharma Tour / BioNJ Partnering is a great opportunity for American companies to meet dynamic and innovative French companies. Come to the French Sourcing Pharma Tour, present your offer and meet with future partners. Follow us on twitter and join our French / North-American Healthcare Business Group on LinkedIn    

Chicago, June 28, 2011 (word count: 349) Established on February 1, 2011 in the Bordeaux area, Bordeaux Clinical Research Network (BCRN) is a service platform dedicated to clinical trials in the healthcare industry. It aims to fulfill the increasing requirements of CROs and healthcare professionals to boost and speed up patient inclusion in phase I to IV clinical trials, while still ensuring compliance with all applicable quality standards. BCRN offers international pharmaceutical companies and CROs a unique clinical trial platform in France, with easy access to a significant number of patients in a wide range of therapeutic fields.   For the first time in Europe industries, hospitals and universities have joined forces to achieve the following goals: - Obtain higher patient inclusion rates in high-potential clinical trials - Provide industries and hospitals with a unique gateway and enable them to connect, to effectively streamline procedures and to reduce lead time on trials - Strengthen the relationship between hospitals and primary-care providers to optimize patients enrollment   BCRN is a Site Management Organization (SMO) offering a wide range of services including: 1/ Assistance in setting up clinical trials - Analyzing protocols and identifying investigators - Defining logistical requirements and offering adequate services - Elaborating budgets and financial proposals - Providing a single contract for all parties involved 2/ Reinforcement of investigation/site management capabilities - Allocating and managing medical and paramedical staff - Increasing the involvement of primary-care providers in the enrollment, inclusion and monitoring of patients - Assuring administrative and logistical support to the primary-care providers’ network 3/ Support to innovative projects - Analyzing the various requirements - Drafting agreements - Identifying means of investigation - Assisting with regulatory procedures - Implementing and supervising projects   BCRN combines the assets and skills of its co-founders : - Bordeaux University Hospital - The Bergonié Institute (Regional Cancer Center) - Bordeaux Segalen University - SARI (Société d’Accompagnement à la Recherche Industrielle), a French company dedicated to the support of industrial research. This company was set up by the Bordeaux Chamber of Commerce and Industry and brings together twelve local SMEs specialized in pharmaceuticals, medical devices and nutrition.   For more information, please contact: GIE BORDEAUX RECHERCHE CLINIQUE BORDEAUX CLINICAL RESEARCH NETWORK Marie-Odile Vergez 2 rue Dubernat 33400 Talence FRANCE Tel.: + 33 6 89 86 53 09 E-mail: contact@bordeaux-clinicalresearch.com  

UBIFRANCE – French Trade Commission is proud to present this year again the French Pavilion at the BIO International Convention. Clusters, public agencies, research laboratories and French companies specialized in infectious diseases, immunology, genetics, nutrition & health, cancer and more will be exhibiting at the booth 2505. The major French clusters in biotechnologies will be presenting their activities and looking for new opportunities of partnerships: News!  Lyonbiopôle has been selected by the organizers of the show and will be presenting at the International Case Studies Session, on the following theme: “Vaccine Innovation, a Collaborative Approach: from Diagnosis to Prevention and Treatment” We hope to see you there, on Wednesday, June 29, from 4 to 4.45 p.m., Room 145B, Level 1 . UBIFRANCE also cordially invites you to its “French Hospitalities Reception”, which will be held on the Pavilion, on Tuesday, June 28 – a great way to discuss business opportunities, while tasting delicious French regional products! Make sure to stop by, grab a bite and meet with the 121 exhibiting companies and partners. Download the press kit or check out the Pavilion’s brochure for more details about our partners and exhibiting companies. UBIFRANCE’s Partners on the Pavilion   Exhibitors on the French Pavilion   Contact us for more information.